Comparison of pioglitazone and linaglipti
Phase 3
Recruiting
- Conditions
- Type 2 diabetes mellitus.Type 2 diabetes mellitus
- Registration Number
- IRCT20170513033941N66
- Lead Sponsor
- Kashan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Patients diagnosed with type 2 diabetes
Individuals aged 30-50 years old
FBS =140
under treatment with metformin for at least 3 months
Exclusion Criteria
Secondary diabetes due to cushing syndrome, acromegaly and other diseases
systemic inflammatory diseases such as rheumatoid arthritis, IBD, vasculitis, etc.
renal or liver or heart failure
malignancy
under insulin therapy
pregnancy
unwillingness to cooperate
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Fasting blood glucose levels. Timepoint: At the beginning of the study and after 3 months of intervention. Method of measurement: Enzymatic kit.
- Secondary Outcome Measures
Name Time Method